503068-31-3 Usage
Uses
Used in Research and Experimental Studies:
Benzene, [[2-[(6-bromohexyl)oxy]ethoxy]methyl]is employed as a research chemical for studying its properties and potential applications. Its unique structure allows scientists to explore its interactions with other compounds and its behavior under various conditions.
Used in Chemical Synthesis:
In the chemical industry, Benzene, [[2-[(6-bromohexyl)oxy]ethoxy]methyl]may be used as an intermediate in the synthesis of more complex molecules. Its bromohexyl and ethoxy groups can be further modified or used as building blocks for creating novel compounds with specific functions.
Used in Pharmaceutical Development:
Due to its structural features, Benzene, [[2-[(6-bromohexyl)oxy]ethoxy]methyl]could potentially be used in the development of new pharmaceuticals. Its benzene ring and functional groups may contribute to the compound's biological activity, making it a candidate for drug discovery and medicinal chemistry research.
Used in Material Science:
In material science, Benzene, [[2-[(6-bromohexyl)oxy]ethoxy]methyl]may have applications in the development of new materials with specific properties. Its chemical structure could influence the material's stability, solubility, or reactivity, making it suitable for various applications such as coatings, adhesives, or polymers.
Used in Environmental Applications:
Benzene, [[2-[(6-bromohexyl)oxy]ethoxy]methyl]may also find use in environmental applications, such as in the development of new methods for pollution control or remediation. Its chemical properties could be harnessed to interact with pollutants or contaminants, facilitating their removal or degradation.
Check Digit Verification of cas no
The CAS Registry Mumber 503068-31-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,0,6 and 8 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 503068-31:
(8*5)+(7*0)+(6*3)+(5*0)+(4*6)+(3*8)+(2*3)+(1*1)=113
113 % 10 = 3
So 503068-31-3 is a valid CAS Registry Number.
503068-31-3Relevant academic research and scientific papers
Benzoxazine compound and its preparation methods and application
-
Paragraph 0093; 0096; 0097, (2017/10/07)
The invention relates to a benzoxazine compound represented in the following formula 1. The benzoxazine compound can serve as a beta 2 receptor agonist. The formula can be seen from the description.
Synthesis and structure-activity relationships of long-acting β2 adrenergic receptor agonists incorporating metabolic inactivation: An antedrug approach
Procopiou, Panayiotis A.,Barrett, Victoria J.,Bevan, Nicola J.,Biggadike, Keith,Box, Philip C.,Butchers, Peter R.,Coe, Diane M.,Conroy, Richard,Emmons, Amanda,Ford, Alison J.,Holmes, Duncan S.,Horsley, Helen,Kerr, Fern,Li-Kwai-Cheung, Anne-Marie,Looker, Brian E.,Mann, Inderjit S.,McLay, Iain M.,Morrison, Valerie S.,Mutch, Peter J.,Smith, Claire E.,Tomlin, Paula
supporting information; experimental part, p. 4522 - 4530 (2010/08/07)
A series of saligenin β2 adrenoceptor agonist antedrugs having high clearance were prepared by reacting a protected saligenin oxazolidinone with protected hydroxyethoxyalkoxyalkyl bromides, followed by removal of the hydroxy-protecting group, alkylation, and final deprotection. The compounds were screened for β2, β1, and β3 agonist activity in CHO cells. The onset and duration of action in vitro of selected compounds were assessed on isolated superfused guinea pig trachea. Compound 13f had high potency, selectivity, fast onset, and long duration of action in vitro and was found to have long duration in vivo, low oral bioavailability in the rat, and to be rapidly metabolized. Crystalline salts of 13f (vilanterol) were identified that had suitable properties for inhaled administration. A proposed binding mode for 13f to the β2-receptor is presented.
DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR
-
Page/Page column 21, (2008/06/13)
This invention is directed to compounds of formula (I): to pharmaceutical compositions comprising them; to combination products comprising them; and to their use in therapy.
